Skip to content

Micro­graphia Bio

Using machine learning to turn spatial proteomics into a drug discovery engine

If it were possible to watch drugs molecules at work under a microscope — seeing precisely how they act on different proteins inside cells — it would revo­lu­tionize drug development. Micro­graphia is doing just that. The company uses machine learning to analyze microscopy images at high throughput, allowing researchers and drug developers to unravel disease mechanisms at the subcellular level.

Explore Companies